---
title: "Lyell Immunopharma (LYEL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LYEL.US/norm.md"
symbol: "LYEL.US"
name: "Lyell Immunopharma"
parent: "https://longbridge.com/en/quote/LYEL.US.md"
datetime: "2026-05-20T18:26:40.689Z"
locales:
  - [en](https://longbridge.com/en/quote/LYEL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LYEL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LYEL.US/norm.md)
---

# Lyell Immunopharma (LYEL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.10 | -6.86 | -2.13 | -2.89 | -3.54 |
| ROE | -37.03% | -195.00% | -49.48% | -53.74% | -58.05% |
| Revenue | 2000.00 | 6000.00 | 15000.00 | 8000.00 | 7000.00 |
| Net income | -24.15M | -140.72M | -38.85M | -42.68M | -52.20M |
| Operating income | -44.26M | -61.48M | -37.25M | -43.30M | -56.08M |
| Gross margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net margin | -1207650.00% | -2345383.33% | -258973.33% | -533550.00% | -745642.86% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 350.63M | 340.05M | 407.96M | 385.45M | 429.80M |
| Leverage | 1.28 | 1.37 | 1.24 | 1.29 | 1.28 |
| BVPS | 12.88 | 11.68 | 17.06 | 20.16 | 22.79 |
| Turnover | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 0.0001 |
| Cash & STI | 254.02M | 247.22M | 319.62M | 276.79M | 301.18M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 50.55M | 53.64M | 56.63M | 60.07M | 67.77M |
| Net debt | -221.49M | -196.23M | -266.55M | -241.74M | -273.04M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -38.51M | -32.25M | -28.58M | -34.46M | -54.74M |
| Investing CF | 17.38M | -31.36M | 3.35M | 12.65M | 69.47M |
| Financing CF | 51.72M | 222000.00 | 50.00M | 183000.00 | 1000.00 |
| Free CF | -28.37M | 1.35M | -24.00M | -21.17M | -37.53M |
| OCF coverage | -43269.66% | -10608.88% | -46091.94% | -20510.71% | -22251.22% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -89000.00 | -304000.00 | -62000.00 | -168000.00 | -246000.00 |